Equities

Autonomix Medical Inc

AMIX:NAQ

Autonomix Medical Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)2.28
  • Today's Change0.16 / 7.55%
  • Shares traded77.43k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Autonomix Medical, Inc. is a medical device company, which is focused on advancing technologies to treat diseases involving the peripheral nervous system. Its technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times sensitivity. It is developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation, and chronic pain management across a disease spectrum. Its Autonomix catheter is equipped with a microchip that converts analog signals from the body to a digital signal that can be sent directly to a computer screen.

  • Revenue in USD (TTM)0.00
  • Net income in USD-10.68m
  • Incorporated2014
  • Employees3.00
  • Location
    Autonomix Medical Inc21 Waterway Ave, Suite 300THE WOODLANDS 77380United StatesUSA
  • Phone+1 (832) 277-7816
  • Websitehttps://autonomix.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Harvard Apparatus Regenertv Tchnlgy Inc160.00k-8.08m35.07m10.00--195.26--219.20-0.5824-0.58240.01150.01260.0474----16,000.00-239.52-330.30-507.69-1,524.8877.50---5,053.13-35,138.840.2558--0.7407-------44.28---39.07--
BioRegenx Inc22.24k-571.17k35.40m10.00------1,591.52-0.0021-0.00210.00008-0.00080.4899----2,224.00-1,258.22------96.85---2,568.21-----13.2366.29---47.25---629.37------
iCAD Inc17.94m-5.14m38.48m67.00--1.18--2.15-0.1982-0.08940.69151.230.40810.91992.47267,731.30-11.70-23.94-14.93-34.1485.6076.96-28.66-45.024.59--0.00---12.54-7.5329.32--23.88--
electroCore, Inc.18.69m-16.47m38.62m68.00--8.59--2.07-2.85-2.853.130.74861.161.3054.34274,897.10-102.35-70.73-177.94-88.9682.7075.81-88.12-352.821.18--0.00--86.5774.4215.02---5.88--
Precision Optics Corporation Inc19.41m-1.64m39.02m84.00--3.47--2.01-0.2706-0.27063.241.861.064.304.51231,098.50-8.98-6.71-13.18-10.5533.6533.65-8.43-5.021.05-8.860.1982--34.2339.1284.42--19.39--
IRIDEX Corp49.92m-10.94m39.49m111.00--6.09--0.7911-0.6759-0.67593.080.39921.332.667.42449,765.80-29.16-19.54-47.74-27.4640.7242.67-21.92-15.451.03--0.00---8.964.02-26.81---24.35--
Inspira Technologies Oxy BHN Ltd0.00-11.29m39.77m37.00--6.27-----0.9549-0.95490.000.36660.00----0.00-88.60-114.98-108.36-159.56------------0.00------24.64------
DarioHealth Corp19.04m-59.90m42.79m276.00--0.5395--2.25-2.04-2.040.6332.650.15552.343.5769,000.00-43.90-73.26-51.33-87.5927.5629.54-282.38-293.542.67--0.2673---26.4122.450.5091--52.42--
Autonomix Medical Inc0.00-10.68m42.85m3.00---------0.5055-0.50550.00-0.2649------0.00----------------------------84.50------
Cutera Inc196.64m-157.56m43.16m430.00------0.2195-7.89-7.899.86-9.600.48642.294.43457,293.00-38.97-22.00-50.24-30.7216.4247.63-80.13-27.242.22-43.941.84---15.865.47-97.76--85.87--
Vaso Corp80.54m3.18m44.52m300.0012.271.7410.890.55280.02070.02070.45890.14591.1620.037.77268,470.004.577.607.4416.6261.8358.393.955.821.37--0.0091--2.181.84-57.46---22.33--
Lucid Diagnostics Inc2.98m-54.53m46.41m70.00------15.56-1.27-1.270.06980.25440.0735--78.5042,614.29-115.88---248.82---111.06---1,576.63--1.36--0.5579--544.03--6.24------
Envoy Medical Inc297.00k-22.43m46.45m34.00------156.40-2.21-2.210.0194-0.37820.04940.47372.368,735.29-381.38---2,885.46---118.18---7,718.86--0.8969-16.54----33.33---87.83------
United Health Products Inc0.00-1.93m47.06m6.00---------0.008-0.0080.00-0.00730.000.00--0.00-719.43-6,446.86------53.19---132,561.200.0483-15.60-----100.00---55.45------
Cytosorbents Corp36.69m-27.54m48.88m186.00--2.58--1.33-0.5869-0.58690.77480.34860.70194.825.97197,237.50-52.69-36.00-68.27-43.5264.0868.15-75.07-62.711.21-114.700.1896--4.7910.0613.12---9.24--
Data as of May 31 2024. Currency figures normalised to Autonomix Medical Inc's reporting currency: US Dollar USD

Institutional shareholders

0.18%Per cent of shares held by top holders
HolderShares% Held
Geode Capital Management LLCas of 31 Mar 202420.68k0.11%
PNC Bank, NA (Investment Management)as of 31 Mar 20245.00k0.03%
BlackRock Fund Advisorsas of 31 Mar 20244.43k0.02%
Tower Research Capital LLCas of 31 Mar 20241.51k0.01%
RBC Capital Markets LLC (Investment Management)as of 31 Mar 20241.00k0.01%
Global Retirement Partners LLCas of 31 Mar 2024200.000.00%
National Bank Financial, Inc.as of 31 Mar 2024150.000.00%
Wells Fargo Bank, NA (Private Banking)as of 31 Mar 202417.000.00%
JPMorgan Securities LLC (Investment Management)as of 31 Mar 20244.000.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.